WASHINGTON—Cardinal Dolan, archbishop of New York and chairof the U.S. Conference of Catholic Bishops' Committee on Pro-Life Activitiesresponded to new guidelines issued by the Food and Drug Administration (FDA)for the abortion drug, RU-486.
"The FDA has irresponsibly loosened its guidelines for thedangerous abortion drug RU-486 expanding its use an additional three weeks intopregnancy, and allowing provision by non-physicians," he said. "The unofficial,off-label use of RU-486 is now the new normal, paving the way for thedestruction of even more innocent lives, and putting women and girls at riskfor all the life-changing effects of abortion."
"Far from wanting abortion to be 'rare', abortion advocates arecelebrating this expanded use as opening an ever-widening door to abortion.They are equally celebrating the FDA's neglect of women's health. Women havedied from this drug, and many who used it after 8 weeks of pregnancy ended upreturning for surgical abortions. This anguish, too, will now be visited onmore women," Cardinal Dolan said.
He concluded with an offer ofassistance to women: "Any woman who finds herself pregnant may come to Catholicagencies for non-judgmental, caring assistance. Catholic Charities, pregnancyhelp centers, and many parishes stand at the ready to assist those in need."---
Keywords: USCCB, Cardinal Dolan, abortion, FDA, RU-486, abortion pill, healthcare, pro-life, abortion
The best of the USCCB,
right in your inbox
Sign Up for Our Email Newsletter